Archangels - Making The Future

Decision Process

Assuming that the basic criteria for investment are met and that the company has decided that it is seeking equity investment then the following process will be undertaken.

  • The executive will review the business plan and let the company know  whether or not the proposal will be considered further.
  • If it is not suitable for Archangels, we will try and suggest other potential investment sources.
  • If it is considered to be suitable for further investigation, then a meeting will be held with the management team to discuss the plan and the needs of the company.
  • If there is still interest, then some basic due diligence will be undertaken and other members of the syndicate may become involved in the assessment.
  • The company will be asked to present to the Board of Archangels.
  • The investment and other resource needs of the company will be discussed and agreed and an outline deal structure will be set out.
  • Appropriate due diligence and preparation of standard investment agreements etc will commence in parallel.
  • The company will normally be asked to present to a forum of interested potential investor members.
  • A non-executive chairman and a further non-executive director will be identified and agreed with the management team.
  • Any debt or grant requirements will be finalised.
  • Completion of the investment will proceed.
  • No arrangement fee is charged to the company for the initial investment, but there will be an ongoing annual fee to cover central monitoring of performance.

 

Latest News

Touch Bionics unveils the new i-LIMB Pulse

05 May 2010
Touch Bionics today announced the launch of the i-LIMB Pulse, an all-new version of the revolutionary i-LIMB Hand, the wordl's first commercially available bionic hand. The i-LIMB Pulse is a significant advance for the i-LIMB product line, with a host of enhancements, including pulsing grip strength, software-enabled grip patterns and robust aluminium features for improved strength.

Touch Bionics wins prestigious Queen's Award for innovation

21 Apr 2010
Touch Bionics, developer of advanced upper-limb bionic technologies, today announced it is a winner of the prestigious Queen's Awards for Enterprise with an award in the Innovation category for 2010. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance.

Bloxx Delivers Web Filtering Excellence at Wellingborough School

21 Apr 2010
School has immediate access to safe internet surfing with Bloxx Web Filtering. Bloxx today announced that Wellingborough School is providing safe Internet access for around 900 users and achieving superior anonymous proxy detection by using Bloxx's real time Web filtering, powered by its patented Tru-View Technology.

Bloxx helps Yorkshire Building Society keep staff safe online

15 Apr 2010
Bloxx the innovator in Web content filtering, announced on 15th April that Yorkshire Building Society is using Bloxx Web filtering to monitor and report on the Web browsing activity of over 2,000 staff, delivering superior protection from imappropriate or productivity impacting content and minimising network security risks.

New "Penicillin" for the 21st Century

01 Apr 2010
Today MGB Biopharma Limited, a late preclinical stage biopharmaceutical company, has commenced operations in Glasgow, UK to develop and commercialise a new class of antibacterial product: DNA Minor Groove Binders.